Synthesis and SAR studies of novel 2-(4-oxo-2-aryl-quinazolin-3(4H)-yl)acetamide vasopressin V1b receptor antagonists

Synthesis and structure-activity relationships (SAR) of a novel series of vasopressin V_1b (V₃) antagonists are described. 2-(4-Oxo-2-aryl-quinazolin-3(4H)-yl)acetamides have been identified with low nanomolar affinity for the V_1b receptor and good selectivity with respect to related receptors V_1a, V₂ and oxytocin (OT). Optimised compound 12j demonstrates a good pharmacokinetic profile and activity in a mechanistic model of HPA dysfunction.     

Synthesis,characterization, and molecular structure of the quadruply bonded ditungsten(ll) complex,W2Cl4(dppm)2

The reaction of W₂Cl₄[P(n-Bu)₃]₄ with bis(diphenylphosphino)methane (dppm) affords the highly air-sensitive material, W₂Cl₄(dppm)₂, which has been characterized by IR and visible spectroscopy, and by X-ray crystallography. The compound crystallizes in the centrosymmetric space group C2/c with the following parameters: a = 17.298(3); b = 17.011- (2); c = 18.413(2) Å; β = 98.93(2); V = 5352(2) ų; Z = 4. The molecule is positioned about a C₂ axis which allows for a net torsion angle of 17.25° down the WW vector. This does not seem to significantly effect the WW bond distance (2.269(1) Å) relative to other quadruply bonded ditungsten species.     

C(2)H(4): Its Incorporation and Metabolism by Pea Seedlings under Aseptic Conditions

The effects of various treatments on the recently reported system in pea (Pisum sativum cv. Alaska), which results in (a) the incorporation of ¹⁴C₂H₄ into the tissue and (b) the conversion of ¹⁴C₂H₄ to ¹⁴CO₂, was investigated using 2-day-old etiolated seedlings which exhibit a maximum response. Heat treatment (80 C, 1 min) completely inhibited both a and b, whereas homogenization completely inhibited b but only partially inhibited a. Detaching the cotyledons from the root-shoot axis immediately before exposing the detached cotyledons together with the root-shoot axis to ¹⁴C₂H₄ markedly reduced both a and b. Increasing the ¹⁴C₂H₄ concentration from 0.14 to over 100 μl/l progressively increased the rate of a and b with tissue incorporation being greater than ¹⁴C₂H₄ to ¹⁴CO₂ conversion only below 0.3 μl/l ¹⁴C₂H₄. Reduction of the O₂ concentration reduced both a and b, with over 99% inhibition occurring under anaerobic conditions. The addition of CO₂ (5%) severely inhibited ¹⁴C₂H₄ to ¹⁴CO₂ conversion without significantly affecting tissue incorporation. Exposure of etiolated seedlings to fluorescent light during ¹⁴C₂H₄ treatment was without effect. Similarly, indoleacetic acid, gibberellic acid, benzyladenine, abscisic acid, and dibutyryl cyclic adenosine monophosphate had no significant effect on either a or b.     

The crystal and molecular structures of dichloro [N,O-(D,L)-diaminopropionic acid] platinum(II) and Dichloro [N,O-(L)-lysine] platinum(II) monohydrate

K₂PtCl₄ reacts with L-lysine and with D,L-diaminiopropionic acid (Dap) forming the neutral complexes [PtCl₂(N,O-Lys)]·H₂0 (1) and [PtCl₂(N,O-Dap)], (2) respectively.Compound 1 is monoclinic, space group P2₁ with a = 11.262(3), b = 11.041(2), c = 9.690(2) Å, β = 102.07(5)°, V = 1178(1) ų and Z = 4. Compound 2 is monoclinic, space group P2₁/n with a = 8.777(1), b = 10.615(2), c = 7.947(1) Å, β = 94.98(3)°, V = 738(1) ų and Z = 4. In both compounds, the zwitterionic ligands form an N,O-five membered chelate with the platinum atom. Structures 1 and 2 were refined to R values of 3.3% and 6.3% respectively.     

Synthesis,structure, reactivity and electrochemistry of a new molybdenum(0) dithiocarbamato complex, [Et4N][Mo(CO)4(S2CNEt2)]

A new molybdenum(0) dithiocarbamato complex [Et₄N] [Mo(CO)₄(S₂CNEt₂)] (1) has been synthesized by the reaction of Mo(CO)₆, NaS₂CNEt₂ and Et₄NCl in MeCN and characterized by routine elemental analysis, spectroscopy methods. The crystal and molecular structure of 1 was determined from X-ray three dimension data. 1 crystallizes in the orthorhombic, space group Pbc2₁ with a= 8.148(2), b=19.618(2), c=14.354(2) Å; V=2294 ų; Z=4; R₁=0.052, R₂=0.058 for 1308 independent reflections with I ⩾ 3σ(I). The geometry around Mo(0) atom in the anion [Mo(CO)₄(S₂CNEt₂)]^- of 1 is distorted octahedral with a small SMoS of 67.70° and a small angle of 3.6° between plane MoSS and MoC(1)C(2). Two groups of MoCO bond distances and the longer MoS bond distance observed in 1 are similar to that in the dinuclear Mo(0) complexes containing SR bridges but very different from those observed in the dithiocarbamato complexes of Mo in higher oxidation states. Different oxidizing products containing Mo in II-V oxidation states Mo(CO)₂(S₂CNEt₂)₂, MoO(S₂CNEt₂)₂, Mo₂O₃(S₂CNEt₂)₄ and Mo₂O₄(S₂CNEt₂)₂ were isolated from the oxidation of 1 with I₂ (or in the presence of traces of air). The electrochemical behavior of 1 in MeCN was investigated by cyclic voltammetry at Pt and C electrodes. The anodic peaks observed at 0.04, 0.14, 0.26 and 0.44 V versus SCE implied that 1 probably underwent oxidation in company with dissociation of dithiocarbamate and substitution of carbonyls resulting in several complexes of Mo in different oxidation states. The relationship between reactivity and structure is also discussed.     

Preparation,structure and properties of dicyano silver complexes of the M(en)3Ag2(CN)4 and M(en)2Ag2(CN)4 type

Complexes of the M(en)₃Ag₂(CN)₄ (M = Ni, Zn, Cd) and M(en)₂Ag₂(CN)₄ (M = Ni, Cu, Zn, Cd) type were prepared and identified by elemental analysis, infrared spectroscopy, measurement of magnetic susceptibility, and X-ray powder diffractometry. The crystal structures of Ni(en)₃Ag₂(CN)₄ (I) and Zn(en)₂Ag₂(CN)₄ (II) were determined by the method of monocrystal structure analysis. Complex I crystallizes in the space group C2/c, a = 1.2639(5), b = 1.3739(4), c = 1.2494(4) nm, β = 113.25(4)°, D_m = 1.86(1), D_c = 1.86 gcm⁻³ Z = 4, R = 0.0429. The crystal structure of I consists of complex cations [Ni(en)₃]²⁺ and complex anions [Ag(CN)₂]⁻. Complex II crystallizes in the space group I2/m, a = 0.9150(3), b = 1.3308(4), c = 0.6442(2) nm, β = 95.80(3)°, D_m = 2.14(1), D_c = 2.15 gcm⁻³, Z = 2, R = 0.0334. Its crystal structure consists of infinite, positively charged chains of the [-NCAgCNZn- (en)₂]_nⁿ⁺ type and isolated [Ag(CN)₂]⁻ anions. The atoms of Ag are positioned parallely to the z axis and the AgAg distance is equal to 0.3221(2) nm.     

Metal—phenoxyalkanoic acid interactions. Part 14. The crystal and molecular structures of diaquabis(4-fluorophenoxyacetato)copper(II) bis(4-fluorophenoxyacetic acid)dihydrate and tetra-μ-(4-fluorophenoxyacetato-0,0′)-bis[(2-aminopyrimidine)copper(II)]

The crystal structures of two copper(II) complexes of 4-fluorophenoxyacetic acid (4-FPAH) have been determined by X-ray diffraction. [Cu(4-FPA)₂(H₂O)₂]·2(4-FPAH)·2H₂O (1) is triclinic, space group P1 with Z = 1 in a cell of dimensions a = 14.808(2), b = 9.832(2), c = 6.847(2) Å, α = 87.77(2), β = 98.41(2), γ = 112.33(2)° and was refined to a residual of 0.038 for 1697 ‘observed’ reflections. The coordination sphere in this complex is tetragonally distorted octahedral comprising two waters [CuO, 1.940(3) Å], two unidentate carboxylate oxygens [CuO, 1.942(2) Å] and two ether oxygens [CuO, 2.471(2) Å]. Two adducted [4-FPAH] acid molecules are linked to the un-coordinated oxygens of the acid ligands by hydrogen bonds [2.547(4) Å]. [Cu₂(4-FPA)₄(2-aminopyrimidine)₂] (2) is triclinic, space group P1 with Z = 1 in a cell of dimensions a = 12.688(2), b = 11.422(2), c = 7.951(1) Å, α = 78.74(1), β = 107.51(1), γ = 75.78(1)°, and was refined to a residual of 0.042 for 2683 ‘observed’ reflections. (2) is a centrosymmetric tetracarboxylate bridged dimer with four similar CuO (equatorial) distances [1.967–1.987 Å; 1.977(3) Å mean] and the axial position occupied by the hetero nitrogen of the 2-aminopyrimidine ligand [CuN, 2.176(3) Å]. The Cu---Cu separation is 2.710(1) Å. Crystal data are also presented which confirm the isostructurality of complex (2) with [Cu₂(phenoxyacetate)₄(2-aminopyrimidine)₂], the Co^II, Mg^II and Mn^II4-fluorophenoxyacetate complexes with their phenoxyacetic and 4-chlorophenoxyacetic acid analogues, and of Cd^II4-fluorophenoxyacetate with Cd^II and Zn^II phenoxyacetates.     

New preparations and molecular structures of cis-MCl2(Ph2PCH2PPh2)2, M = Ru,Os and trans-RuCl2(Ph2PCH2PPh2)2

The title compounds were made by reacting bis(diphenylphosphino)methane (dppm) with reduced solutions of OsCl₆^4? and Ru₂OCl₁₀^4?. The crystal and molecular structures of these compounds have been determined form three-dimensional X-ray study. The cis-isomers crystallize with one CHCl₃ per molecule of the complex. All three compounds crystallize in the monoclinic space group P2₁/n with unit cell dimensions as follows: Cis-OsCl₂(dppm)₂·CHCl₃: a = 13.415(4) Å, b = 22.859(4) Å, c = 16.693(3) Å, β = 105.77(3)°, V = 4926(3) ų, Z = 4. cis-RuCl₂(dppm)₂·CHCl₃: a = 13.442(3) Å, b = 22.833(7) Å, c = 16.750(4) Å, β = 105.53(2)°, V = 4953(3) ų, Z = 4. trans-RuCl₂(dppm)₂: a = 11.368(7) Å, b = 10.656(6) Å, c = 18.832(12) Å; β = 103.90(6)°, V = 2213(7) ų; Z = 2. The structures were refined to R = 0.044 (R_w = 0.055) for cis-OsCl₂(dppm)₂·CHCl₃; R = 0.065 (R_w = 0.079) for cis-RuCl₂(dppm)₂·CHCl₃ and R = 0.028 (R_w = 0.038) for trans-RuCl₂(dppm)₂. The complexes are six coordinate with stable four-membered chelate rings. The PMP angle in the chelate rings is ca. 71° in each case.     

Synthesis of the donor-acceptor ligand 2-(4-dimethylaminobenzylidene)-4,5-bis(diphenylphosphino)-4-cyclopenten-1,3-dione (dbpcd) and X-ray diffraction structure of the platinum(II) compound PtCl2(dbpcd)·1.5CH2Cl2

Knoevenagel condensation of 4-(dimethylamino)benzaldehyde with 4,5-bis(diphenylphosphino)-4-cyclopenten-1,3-dione (bpcd) gives the donor-acceptor ligand 2-(4-dimethylaminobenzylidene)-4,5-bis(diphenylphosphino)-4-cyclopenten-1,3-dione (dbpcd). The reaction of dbpcd with PtCl₂(cod) affords the platinum(II) complex PtCl₂(dbpcd) in high yield. The free dbpcd ligand and PtCl₂(dbpcd) have been isolated and fully characterized in solution by IR and NMR spectroscopies, and the solid-state structure of PtCl₂(dbpcd) determined by X-ray diffraction analysis. PtCl₂(dbpcd), as the 1.5CH₂Cl₂ solvate, crystallizes in the triclinic space group , a = 11.7412(7) Å, b = 12.0486(7) Å, c = 14.4781(9) Å, α = 82.866(1), β = 75.049(1), γ = 83.905(1), V = 1957.6(2) Å³, Z = 2, and D_calc = 1.678 mg/m³, R = 0.0291 and wR₂ = 0.0723 for 8315 reflections with I > 2σ(I). The molecular structure of PtCl₂(dbpcd)·1.5CH₂Cl₂ consists of a square-planar platinum architecture containing two chlorines and the ancillary dbpcd diphosphine ligand. The redox properties of the dbpcd ligand and PtCl₂(dbpcd) have been explored by cyclic voltammetry, and these data are discussed with respect to extended Hückel MO calculations.     

Synthesis and crystal structure of the low-spin iron(II) complex [Fe(bpz)3](ClO4)2 · H2O (bpz=2,2-bipyrazine)

The crystal structure of the title compound [Fe(bpz)₃](ClO₄)₂ · H₂O (bpz=2,2^′-bipyrazine) has been determined by a single crystal X-ray diffraction study at 293(2) K. The complex is monoclinic, P2₁/c, a=17.263(3), b=9.983(2), c=17.921(4) Å, β=107.94(3)°, V=2938.3(10) ų, Z=4, R=0.073 and R_w=0.118. The structure is made up of tris-chelated [Fe(bpz)₃]²⁺ cations, uncoordinated perchlorate anions and crystallization water molecules. The iron atom exhibits a FeN₆ distorted octahedral geometry with average Fe-N bond length and N-Fe-N bidentate angle of 1.962(5) Å and 81.6(2)°. The value of the Fe-N bond distance and that of the room temperature magnetic moment are in agreement with a singlet ¹A₁ ground state. The structure of 1 is compared to those of other tris-chelated iron(II) complexes with bidentate nitrogen heterocycles.     

Synthesis and crystal structure of bis(tetramethylammonium) aquotetra-fluorodioxouranate(VI) dihydrate, [(CI3)4 N]2[UO2 F4(H2 O)]·2H2O

The title compound has been synthesized and subjected to crystal structure analysis. M_r = 548.50, m.p. 108.1 °C (decom.), orthorhombic, Im2m,a = 7.006(2), b = 8.938(2), c = 13.619(2) Å V = 852.8(3) ų, Z = 2, D_x = 2.136, D_m, (flotation in CCl₄/CH₂I₂) = 2.128 g cm^?3, λ(Mo-Kα) = 0.71069 Å, μ = 90.79 cm^?1, F(000) = 519.89, T = 295 K, final R_F = 0.036 and R_G = 0.044 for 566 observed reflections. The discrete [UO₂F₄(H₂0)]^2? anion has site symmetry m2m, its virtually linear uranyl moiety being surrounded by fluoro and aquo ligands occupying the vertices of a pentagon in the equatorial plane. Watet molecules serve to link the complex anions by hydrogen bonds into layers, between which the organic cations are accommodated.     

Trimethylsilyloxo complexes of oxomolybdenum(V)

The complexes LMo^VIO₂X [L?=?hydrotris(3,5-dimethylpyrazol-1-yl)borate; X?=?Cl, Br, NCS, OPh, SPh, SCH₂Ph] are converted to air-stable complexes LMo^VO(OSiMe₃)X by one-electron coupled electron-electrophile transfer (CEET) reactions involving cobaltocene and the electrophilic reagent Me₃SiCl. These complexes may also be obtained from LMo^VO(OH)X by reaction with Me₃SiCl in the presence of base. LMo^VO(OSiMe₃)(SCH₂Ph) crystallises in space group P2₁/n, with a?=?8.526 (1) Å, b?=?23.141 (3) Å, c?=?16.499 (2) Å, β?=?103.75 (12)° and Z?=?4. The complex exhibits a distorted octahedral structure with a facially tridentate L ligand and mutually cis oxo [Mo=O?=?1.675 (4) Å], silyloxo [Mo–O?=?1.932 (4) Å] and thiolato [Mo–S?=?2.398 (2) Å] ligands. The detailed redox properties of LMo^VO(OR)X (R?=?SiMe₃, alkyl, aryl) differ from those of LMo^VO(OH)X. Centres [Mo^VO(OR)] are candidates for the stable "inhibited" forms of certain molybdenum enzymes formed under conditions which apparently disfavour the catalytically active [Mo^VO(OH)] centres. In the coordinating solvent pyridine (py), both LMo^VIO₂(SPh) and LMo^VO(OSiMe₃)(SPh) are reduced in one-electron steps to stable LMo^IVO(py)(SPh). LMo^IVO(py)(SR) complexes are also obtained from LMo^VIO₂(SR) (R?=?Ph, CH₂Ph, CHMe₂) via a two-electron oxygen atom transfer reaction with tertiary phosphines in pyridine. Consequently, the Mo(IV) product is accessible via a concerted two-electron step or via two one-electron steps.     

The preparation and x-ray crystal structures of bis(4R-oxazolidine-4′-carboxylato)copper(II) (R = methyl,phenyl)

The base-catalyzed condensation reactions of formaldehyde with the copper(II) chelates of α-alanine and C-phenylglycine result in the formation of bis(4R-oxazolidine-4′-carboxylato)copper(II) where R = methyl and phenyl respectively. The 4-methyl complex, C₁₀H₂₀N₂O₈Cu, crystallizes in the monoclinic space group P2₁/n with a = 9.141(2), b = 7.335(3), c = 11.112(3) Å, β = 103.87(2)° and Z = 2. The structure has been refined to R = 0.026 and R_w = 0.031 based on 749 independent reflections collected, 651 used. The geometry about copper is essentially a (4 + 2)-elongated octahedral structure. The 4-phenyl derivative, C₂₀H₂₀N₂O₆Cu, crystallizes in the monoclinic space group P2₁/c with a = 11.939(4), b = 8.887(2), c = 8.611(3) Å, β = 95.61(3)° and Z = 2. Refinement of the structure converged to R = 0.062 and R_w = 0.071 based on 1003 reflections collected and 865 used. The structure of the 4-phenyl complex resembles that of the 4-methyl derivative and differs mainly from the latter in being anhydrous.     

Synthesis and molecular modeling studies of 3-chloro-4-substituted-1-(8-hydroxy-quinolin-5-yl)-azetidin-2-ones as novel anti-filarial agents

A series of 3-chloro-4-substituted-1-(8-hydroxy-quinolin-5-yl)-azetidin-2-ones were synthesized and evaluated for their in vitro anti-filarial activity. To pre-assess the anti-filarial behavior of synthesized compounds (V_a–f) on a structural basis, automated docking studies were carried out with Molecular Design Suite (MDS v 3.5) into the active site of glutathione-S-transferase (GST) enzyme; scoring functions of these compounds at the active site of the GST enzyme were used for correlation with observed activity. Compounds V_e and V_f have shown good affinity for receptor GST, as well as in vitro anti-filarial potency.     

Synthesis of copper-zinc bimetallic imidazolate framework compounds and the structure of Cu(I)-containing Cu2Zn(N2C3H3)4

Copper(II)-zinc(II) bimetallic imidazolate metal-organic framework compounds of composition Cu_aZn_bIm_2(a + b) (Im = C₃H₃N₂), including Cu₂ZnIm₆ (1), were prepared in high yields from the metal oxides under mild aqueous conditions using a novel acid catalysis method. Mild acidic hydrothermal treatment of paramagnetic 1 (≥120 °C) gave diamagnetic Cu(I)-containing Cu₂ZnIm₄ (2) in high yield. The formation mechanism of 2 involves electron transfer from Im⁻ to Cu(II), with concomitant formation of the unusual cyclotriimidazole, C₉H₆N₆. Air-stable 2, characterized by single-crystal X-ray diffraction, crystallized in the tetragonal space group , with a = b = 10.9623(3), c = 6.3231(4) Å, α = β = γ = 90°, V = 759.86(6) Å³, and Z = 1.     

Exploration of N-(2-aminoethyl)piperidine-4-carboxamide as a potential scaffold for development of VEGFR-2, ERK-2 and Abl-1 multikinase inhibitor

VEGFR, ERK and Abl had been respectively identified as good drug targets, and their crosstalk also had been well elaborated. Multitarget drugs were more advantageous for cancer treatment, however, no inhibitors simultaneously acting on the three proteins were developed due to their structural diversities. Herein, N-(4-((2-(2-(naphthaen-1-yl)acetamido)ethyl)carbamoyl)piperidin-4-yl)-6-(trifluoromethyl)nicotinamide (NEPT, 6a) was discovered as an active scaffold against VEGFR-2, ERK-2 and Abl-1 kinases through the combination of support vector machine, similarity searching and molecular docking. NEPT and its derivatives were synthesized by convenient routine, their in vitro anti-proliferative abilities against human liver cancer cell line HepG2 were preliminarily evaluated. A representative compound 6b showed an IC₅₀ value of 11.3 μM and induced significant HepG2 cells apoptosis. Besides, these compounds displayed better anti-proliferative abilities against K562 cells (a cell line with typical hyperactivity of the above multikinases), for example compound 6b exhibited an IC₅₀ value of 4.5 μM. Based on hepatotoxicity case reports of Abl inhibitors, cytotoxicity of synthetic compounds against normal liver cell lines (QSG7701 and HL7702) was studied, 6b had a similar toxic effect with positive control imatinib, and most compounds showed less than 35% inhibition activities at 100 μM. Molecular docking study disclosed interactions of 6b with VEGFR-2, ERK-2 and Abl-1 kinases, respectively. Our data suggested the biological activities of 6b may derived from collaborative effects of VEGFR-2, ERK-2 and Abl-1 inhibition.     

Synthesis and structural characterization of trans-[Mo2(H2DMepyF)2(CH3CN)4](BF4)6 (HDMepyF=N,N-di(6-methyl-2-pyridyl)formamidine)

Reaction of Mo₂(O₂CCH₃)₂(DMepyF)₂ (HDMepyF=N,N^′-di(6-methyl-2-pyridyl)formamidine) with HBF₄ in CH₂Cl₂/CH₃CN afforded the complex trans-[Mo₂(H₂DMepyF)₂(CH₃CN)₄](BF₄)₆ (1), which crystallized in two forms, trans-[Mo₂(H₂DMepyF)₂(CH₃CN)₄](ax-CH₃CN)₂(BF ₄)₆ · 2CH₃CN (1a), and trans- [Mo₂(H₂DMepyF)₂(CH₃CN)₄](ax-BF₄) ₂(BF₄)₄ · 2CH₃CN (1b). The molecular structures of complexes (1) consist of two quadruply bonded molybdenum atoms, which are spanned by two trans-bridging formamidinate ligands and coordinated by four trans-CH₃CN. Each H₂DMepyF⁺ ligand adopts an s-cis,s-cis- conformation. The difference between 1a and 1b is that complex 1a contains two CH₃CN molecules as axial ligands, while 1b contains two BF₄⁻ anions as axial ligands. Complex 1 is the first dimolybdenum complex containing a pair of trans bridging ligands and two pairs of trans-CH₃CN ligands.     

Octahedral cyanohydroxo cluster complex trans-[Re6Se8(CN)4(OH)2]: Synthesis, crystal structure, and properties

A hexarhenium cyanohydroxo anionic cluster complex [Re₆Se₈(CN)₄(OH)₂]⁴⁻ was synthesized for the first time starting from [Re₆Se₈(OH)₆]⁴⁻, which was crystallized as a salt of the composition Cs_2.75K_1.25[Re₆Se₈(CN)₄(OH)₂]·H₂O (1). The reaction of the complex with Cu²⁺ in an aqueous ammonia or methylamine solutions afforded [Cu(NH₃)₅]₂[Re₆Se₈(CN)₄(OH)₂]·8H₂O (2) or [{Cu(CH₃NH₂)₄}₂Re₆Se₈(CN)₄(OH)₂] (3), respectively. All of these three compounds were characterized by a single-crystal X-ray diffraction method. Compound 1 is crystallized in the tetragonal space group I4/m with eight formula units per cell (a = b = 17.4823(14) Å, c = 19.430(2) Å, V = 5938.3(10) Å³); compound 2 is crystallized in the monoclinic space group P2₁/n with two formula units per cell (a = 12.1845(13) Å, b = 8.6554(9) Å, c = 19.2568(19) Å, β = 91.081(2)°, V = 2030.5(4) Å³); compound 3 is crystallized in the orthorhombic space group Cmcm with four formula units per cell (a = 19.816(4) Å, b = 14.611(3) Å, c = 13.751(3) Å, V = 3981.2(13) Å³). The luminescence properties of 1 were studied in both aqueous solution and solid state. In addition, the electronic structure of [Re₆Se₈(CN)₄(OH)₂]⁴⁻ was elucidated by DFT calculations.     

A study of cis-dichlorobis(methylamine)platinum(II): Crystal and molecular structures of two crystal forms

A new synthesis of cis-dichlorobis(methylamine)platinum(II) is described. It appears that during the crystallization process at least two types of crystals are formed. Form A is monoclinic with space group P2 ₁/n and unit cell dimensions a = 6.272, b = 15.726, c = 7.419Å, β = 99.86°, V = 721Å ³, Z = 4, R = 0.055. Form B is monoclinic, with space group P2 ₁/c and unit cell dimensions a = 16.078, b = 6.372, c = 21.459Å, β = 92.7°, V = 2196Å ³, Z = 12, R = 0.057. The two forms can be readily distinguished by IR spectroscopy.